Topical pain management with the 5 lidocaine medicated plaster a review
Author
dc.contributor.author
Mick, Gérard
Author
dc.contributor.author
Correa-Illanes, Gerardo
Admission date
dc.date.accessioned
2019-03-11T13:04:02Z
Available date
dc.date.available
2019-03-11T13:04:02Z
Publication date
dc.date.issued
2012
Cita de ítem
dc.identifier.citation
Current Medical Research and Opinion, Volumen 28, Issue 6, 2018, Pages 937-951
Identifier
dc.identifier.issn
03007995
Identifier
dc.identifier.issn
14734877
Identifier
dc.identifier.other
10.1185/03007995.2012.690339
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165596
Abstract
dc.description.abstract
Background: The topical 5 lidocaine medicated plaster is recommended as first-line treatment for localized peripheral neuropathic pain. Scope: In order to provide an overview of the efficacy and safety of the lidocaine plaster in the treatment of different neuropathic pain conditions, all efficacy and safety studies (randomized, controlled, or open-label with well described methodology), case reports, and pharmacological studies on the lidocaine plaster retrieved from a PubMed literature research (1960-March 2012) plus additional references identified from retrieved articles were included. Findings: The lidocaine plaster is efficacious in the treatment of neuropathic pain symptoms associated with previous herpes zoster infection. Results from a large open-label controlled study suggest that the lidocaine plaster could be at least as effective as systemic pregabalin in the treatment of postherpetic neuralgia and painful diabetic polyneuropathy. Open-label studies indicate efficacy in th